Suswapna Singh Rawat: The Role of Platelets in Heart Disease and Antiplatelet Therapy
Suswapna Singh Rawat,Physician shared a post on LinkedIn:
“Platelets play a crucial role in managing ruptures within blood vessels and contributing to blockages in smaller vessels.
While they are essential for clotting, in cases of established heart disease, stents, or bypasses, reducing their activity becomes vital.
Antiplatelet medications like aspirin, clopidogrel, dipyridamole, and ticagrelor are instrumental in these scenarios.
They work by making blood less prone to clotting and aggregation, thereby easing passage through blockages.
For individuals without existing heart conditions, platelets have a less pronounced role, but for those with diagnosed heart disease or recent interventions, these medications are critical.
Management of heart disease is multifactorial, involving measures to reduce blood pressure, inflammation, and LDL cholesterol, alongside controlling platelet activity.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Sep 9, 2026, 14:30Alejandro González Veliz: 2026 ESC Guidelines Expand Cardiac Rehabilitation Beyond Post-Event Recovery
-
Sep 9, 2026, 13:59Natalie Arnold: Biomarkers and the Hidden Burden of CHD
-
Sep 9, 2026, 13:11Ron DePinho: A Negative Trial Does Not Repudiate Inflammation as a Cardiovascular Target
-
Sep 9, 2026, 13:10Ahmad Gharehbaghian: Visiting the Alborz Provincial Blood Transfusion Center
-
Sep 9, 2026, 13:09Oraianthi Fiste: New Collection on Cancer-Associated Thrombosis From Mechanisms to Precision Medicine
-
Sep 9, 2026, 13:07Can Özlü: Can the HALP Score Help Identify Thrombotic Risk in Myeloproliferative Neoplasms?
-
Sep 9, 2026, 13:06Ohanna Cavalcanti Bezerra: Why Does DVT Lead to PE in Some Patients but Not Others?
-
Sep 9, 2026, 13:04Usman Shehzad: Transforming Patient Lives with INR Self-Testing
-
Sep 9, 2026, 13:02Edward Lee Carter: Provoked VTE May Not Tell the Whole Story About Recurrence Risk